53
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Synthesis of A Novel Heterocyclic System of 3,8-Disubstituted-5H-Pyrimido[5’,4’:5,6][1,4]Thiazino[3,2-e][1,2,4]Triazine

&
Pages 1516-1523 | Received 20 Oct 2019, Accepted 15 Jun 2020, Published online: 26 Jun 2020

References

  • A. Ahmad, H. Himani Varshney, A. Rauf, A. Sherwani, and M. Owais, “Synthesis and Anticancer Activity of Long Chain Substituted 1,3,4-Oxadiazol-2-Thione, 1,2,4-Triazol-3-Thione and 1,2,4-Triazolo[3,4-b]-1,3,4-Thiadiazine Derivatives,” Arabian Journal of Chemistry 10 (2017): S3347–S57.
  • A. H. Malani, M. A. Makwana, and H. Makwana, “A Brief Review Article: Various Synthesis and Therapeutic Importance of 1, 2, 4-Triazole and Its Derivatives,” Moroccan Journal of Chemistry 5 (2017): 41–59.
  • T. Karabasanagouda, A. V. Adhikari, and N. Suchetha Shetty, “Synthesis and Antimicrobial Activities of Some Novel 1,2,4-Triazolo[3,4-b]-1,3,4-Thiadiazoles and 1,2,4-Triazolo[3,4-b]-1,3,4-Thiadiazines Carrying Thioalkyl and Sulphonyl Phenoxy Moieties,” European Journal of Medicinal Chemistry 42, no. 4 (2007): 521–9.
  • M. Arshad, T. A. Khan, and M. A. Khan, “1, 2, 4-triazine Derivatives: Synthesis and Biological Applications,” International Journal of Pharmaceutical Sciences and Research 5 (2014): 149.
  • R. Kumar, T. S. Sirohi, H. Singh, R. Yadav, R. K. Roy, A. Chaudhary, and S. N. Pandeya, “1,2,4-Triazine Analogs as Novel Class of Therapeutic Agents,” Mini Reviews in Medicinal Chemistry 14, no. 2 (2014): 168–207.
  • P. Ahuja and N. Siddiqui, “Anticonvulsant Evaluation of Clubbed Indole-1,2,4-Triazine Derivatives: A Synthetic Approach,” European Journal of Medicinal Chemistry 80 (2014): 509–22.
  • H. Irannejad, A. Kebriaieezadeh, A. Zarghi, F. Montazer-Sadegh, A. Shafiee, A. Assadieskandar, and M. Amini, “Synthesis, Docking Simulation, Biological Evaluations and 3D-QSAR Study of 5-Aryl-6-(4-Methylsulfonyl)-3-(Metylthio)-1,2,4-Triazine as Selective Cyclooxygenase-2 Inhibitors,” Bioorganic & Medicinal Chemistry 22, no. 2 (2014): 865–73.
  • K. Ban, S. Duffy, Y. Khakham, V. M. Avery, A. Hughes, O. Montagnat, K. Katneni, E. Ryan, and J. B. Baell, “3-Alkylthio-1,2,4-Triazine Dimers with Potent Antimalarial Activity,” Bioorganic & Medicinal Chemistry Letters 20, no. 20 (2010): 6024–9.
  • L. X. Li, J. Jiao, X. B. Wang, M. Chen, X. C. Fu, W. Si, J. Yang, and C. L. Synthesis, “Characterization, and Antifungal Activity of Novel Benzo[4,5]Imidazo[1,2-d][1,2,4]Triazine Derivatives,” Molecules 23, no. 4 (2018): 746.
  • V. L. Rusinov, I. N. Egorov, O. N. Chupakhin, E. F. Belanov, N. I. Bormotov, and O. A. Serova, “Synthesis and Antiviral Activity of 1,2,4-Triazine Derivatives,” Pharmaceutical Chemistry Journal 45, no. 11 (2012): 655–9.
  • G. Wang, Z. Peng, Z. Gong, and Y. Li, “Synthesis, Biological Evaluation, and Docking Studies of Novel 5,6-Diaryl-1,2,4-Triazine Thiazole Derivatives as a New Class of α-Glucosidase Inhibitors,” Bioorganic Chemistry 78 (2018): 195–200.
  • G. Wang, Z. Peng, J. Wang, X. Li, and J. Li, “Synthesis, In Vitro Evaluation and Molecular Docking Studies of Novel Triazine-Triazole Derivatives as Potential α-Glucosidase Inhibitors,” European Journal of Medicinal Chemistry 125 (2017): 423–9.
  • A. Mohammadi, H. Eshghi, M. Bakavoli, F. Hadizadeh, and H. Moradi, “Synthesis of Novel 3-Substituted-5H-Benzo[5,6][1, 4]Thiazino[3,2-e][1,2,4]Triazines and Their 15-Lipoxygenase Inhibitory Activity,” Journal of the Iranian Chemical Society 13, no. 8 (2016): 1539–47.
  • W. Shi, H. Qiang, D. Huang, X. Bi, W. Huang, and H. Qian, “Exploration of Novel Pyrrolo[2,1-f][1,2,4]Triazine Derivatives with Improved Anticancer Efficacy as Dual Inhibitors of c-Met/VEGFR-2,” European Journal of Medicinal Chemistry 158 (2018): 814–31.
  • M. Mojzych, P. Tarasiuk, Z. Karczmarzyk, M. Juszczak, W. Rzeski, A. Fruzinski, and A. Wozny, “Synthesis, Structure and Antiproliferative Activity of New Pyrazolo[4,3- e]Triazolo[4,5-b][1,2,4]Triazine Derivatives,” Medicinal Chemistry (Shariqah (United Arab Emirates)) 14, no. 1 (2018): 53–9.
  • J. Cossrow, B. Guan, A. Ishchenko, J. H. Jones, G. Kumaravel, A. Lugovskoy, H. Peng, N. Powell, B. C. Raimundo, H. Tanaka, J. Vessels, T. Wynn, Z. Xin. US Patent 20,090,005,359, 2009.
  • C. M. Dehnhardt, A. M. Venkatesan, E. D. Santos, Z. Chen, O. Santos, S. Ayral-Kaloustian, N. Brooijmans, R. Mallon, I. Hollander, L. Feldberg, et al. “ Bis(morpholino-1,3,5-triazine) derivatives: Potent adenosine 5'-triphosphate competitive phosphatidylinositol-3-kinase/mammalian target of rapamycin inhibitors: Discovery of compound 26 (PKI-587), a highly efficacious dual inhibitor,” Journal of Medicinal Chemistry 53, no. 6 (2010): 2636–45.
  • J. J. Wade, C. B. Toso, C. J. Matson, and V. L. Stelzer, “Synthesis and Antiallergic Activity of Some Acidic Derivatives of 4H-Pyrimido[2,1-b]Benzazol-4-Ones,” Journal of Medicinal Chemistry 26, no. 4 (1983): 608–11.
  • S. Gupta, N. Ajmera, N. Gautam, R. Sharma, and D. C. Gautam, “Novel Synthesis and Biological Activity Study of Pyrimido[2,1-b]Benzothiazoles,” ChemInform Abstract 40 (2009): 853–7.
  • B. Dash, M. Patra, and P. K. Mahapatra, “Synthesis of Thiazolo Pyrimidine Derivatives,” Journal of Chemical Sciences (India) 52 (1980): 92–5.
  • A. B. A. El‐Gazzar, M. M. El‐Enany, and M. N. Mahmoud, “Synthesis 2008, Synthesis, Analgesic, anti-Inflammatory, and Antimicrobial Activity of Some Novel Pyrimido[4,5-b]Quinolin-4-Ones,” Bioorganic and Medicinal Chemistry 16 (2007): 3261–73.
  • P. Dinér, J. P. Alao, J. Söderlund, P. Sunnerhagen, and M. Grøtli, “Preparation of 3-Substituted-1-Isopropyl-1H-Pyrazolo[3,4-d]Pyrimidin-4-Amines as RET Kinase Inhibitors,” Journal of Medicinal Chemistry 55 (2012): 4872–6.
  • A. Karimian, H. Eshghi, M. Bakavoli, A. Shiri, M. Saadatmandzadeh, T. Asghari, and H. Moradi, “Dipyrimido[4,5-b:5,4-e][1,4]Thiazine: Synthesis and Their Enzyme Inhibitory Activity Assessment on Soybean 15-Lipoxygenase,” Journal of the Iranian Chemical Society 12, no. 9 (2015): 1501–8.
  • A. Karimian, “Synthesis of New Pyrimido[5′,4′:5,6][1,4]Thiazino[2,3‐b]Quinoxaline Derivatives in One Step,” Journal of Heterocyclic Chemistry 55, no. 3 (2018): 645–9.
  • A. Karimian, H. Eshghi, M. Bakavoli, and A. Shiri, “Synthesis of New Derivatives of 4‐(4,7,7‐Trimethyl‐7,8‐Dihydro‐6H‐Benzo[b]Pyrimido[5,4‐e][1,4]Thiazin‐2‐yl)Morpholine,” Journal of Heterocyclic Chemistry 54, no. 1 (2017): 151–4.
  • S. Sheikhi‐Mohammareh, A. Shiri, M. Bakavoli, and J. Mague, “A Straightforward Approach for the Synthesis of Novel Derivatives of Benzo[b]Pyrazolo[5′,1′:2,3]Pyrimido[4,5‐e][1,4]Thiazine,” Journal of Heterocyclic Chemistry 53, no. 4 (2016): 1231–5.
  • A. Karimian, H. Eshghi, M. Bakavoli, and A. Shiri, “Synthesis of Pyrimido[4′,5′:2,3][1,4]Thiazepino[7,6-b]Quinolines, Derivatives of a Novel Ring System,” Heterocyclic Communications 20 (2014): 275–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.